Open Access Study protocol

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Andre Mihaljevic, Peter Büchler*, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein and Michael Geissler

BMC Surgery 2009, 9:1  doi:10.1186/1471-2482-9-1

Article Metrics

6274
Total accesses


1
BioMed Central citations

Article metric FAQ

Accesses  

  • Last 30 days: 46 accesses
  • Last 365 days: 611 accesses
  • All time: 6274 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information

Cited by

BioMed Central: 1 citation